Overview Treatment of Refractory Status Epilepticus Status: Terminated Trial end date: 2010-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents. Phase: Phase 3 Details Lead Sponsor: Brigham and Women's HospitalTreatments: PentobarbitalPropofolThiopental